Many women are skeptical about the concept of undergoing risk-based breast cancer screening, according to a new study published in the Journal of General Internal Medicine.

The Office of the United States Trade Representative has announced that the U.S. government’s previously announced second round of tariffs on Chinese imports—impacting approximately $16 billion worth of products—is now official.

High-level support and a consensus-based decision-making process are the keys to standardizing CT and MRI protocols across large healthcare centers, a team of Harvard Medical researchers report in the current edition of the Journal of the American College of Radiology.

Aidoc, a Tel-Aviv, Israel-based medical imaging company, announced Wednesday, August 8, that it has gained FDA clearance for its brain solution that helps radiologists flag acute intracranial hemorrhage (ICH) cases using artificial intelligence (AI).

A team of researchers has identified genes associated with being at a greater risk of developing triple-negative breast cancer, according to a new study published in the Journal of the National Cancer Institute. Could this discovery lead to improved patient care?

Multi-trauma patients over 30 years old, as well as those with severe injuries or wounds across three or more body parts, see an increased risk for missed injury during early whole-body CT interpretation, according to research published in Radiology.

Though it’s common practice, imaging hepatocellular carcinoma (HCC) patients one month after selective internal radiation therapy (SIRT) rarely changes case management, a team from Minneapolis, Minnesota, reported in Diagnostic and Interventional Imaging this month. 

Most radiation oncology fellows will go on to hold jobs in academic radiology, according to a report published this week in the International Journal of Radiation Oncology • Biology • Physics. And more than a third of trainees in pediatrics or brachytherapy go on to hold jobs where those fellowship skills aren’t valued.

Mammography services at a Sunrise, Florida, radiology center have been halted by the FDA until staff have sent cautionary letters to patients whose mammogram results might have been faulty, NBC Miami reported this week.